S. Leucht
Clinical Psychology · 2004–2019
A researcher in the Science corpus: 14 papers; trusts 2 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Clinical Psychology — 33 citations into it
- Physiology — 14 citations into it
Whom S. Leucht trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts S. Leucht overall
Papers from S. Leucht's perspective
Ordered by how strongly the researchers S. Leucht trusts endorse each paper. Same corpus, a different order for every researcher.
- The positive and negative syndrome scale (PANSS) for schizophrenia.
- Mortality and causes of death in schizophrenia in Stockholm county, Sweden. (Schizophrenia Research)
- Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of… (European psychiatry)
- Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Rsearch Database. (Archives of General Psychiatry)
- Physical health monitoring of patients with schizophrenia. (American Journal of Psychiatry)
- Second-Generation (Atypical) Antipsychotics and Metabolic Effects (CNS Drugs)
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. (The Lancet)
- Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. (New England Journal of Medicine)
- Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. (American Journal of Psychiatry)
- Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. (New England Journal of Medicine)
Their papers
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. (2013) — 2,295 citations
- Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis (2019) — 1,177 citations
- Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis. (2018) — 2,646 citations
- Dose Equivalents for Antipsychotic Drugs: The DDD Method. (2016) — 690 citations
- Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. (2012) — 847 citations
- Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (2011) — 2,329 citations
- Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level (2011) — 854 citations
- Opioid antagonists for alcohol dependence. (2010) — 635 citations
- Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis (2010) — 677 citations
- Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. (2009) — 1,861 citations
- Physical illness and schizophrenia: a review of the literature (2007) — 677 citations
- What does the PANSS mean? (2005) — 1,173 citations
- Clinical implications of Brief Psychiatric Rating Scale scores. (2005) — 821 citations
- The effect of family interventions on relapse and rehospitalization in schizophrenia--a meta-analysis. (2004) — 643 citations